HTG Molecular Diagnostics, Inc.
USD0.48
+0.00 (+0.00%)
CEO
John L. Lubniewski
IPO Date
2015-05-06
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$0.57
Prev. Close
$0.48
Day Low
$0.48
Day High
$0.48
52W Low
$0.46
52W High
$24.96
Market Cap
$0.00B
Volume
0.73M
| -0.1 |
| 31 Dec 2020 | FY | 53.3% | -244.1% | -144.1% | -59.3% | 0.87 | 4.54 | -0.1 |
| 31 Dec 2019 | FY | 53.6% | -100.5% | -80.5% | -42.8% | 0.47 | 4.65 | -0.1 |
| 31 Dec 2018 | FY | 76.3% | -76.5% | -78.0% | -37.6% | 0.46 | 5.41 | -0.3 |
| 31 Dec 2017 | FY | 66.3% | -128.5% | 619.7% | -89.2% | -2.86 | 1.35 | -0.1 |
| 31 Dec 2016 | FY | 19.4% | -507.3% | 465.6% | -141.1% | -2.11 | 1.51 | -0.0 |
| 31 Dec 2015 | FY | 17.5% | -529.4% | -126.7% | -54.3% | 0.64 | 5.52 | -0.1 |
| 31 Dec 2014 | FY | 3.7% | -419.3% | 58.1% | -159.9% | -0.47 | 1.88 | -0.5 |
| 31 Dec 2013 | FY | -0.2% | -524.7% | 52.4% | -267.6% | -0.00 | 1.39 | -0.6 |
| -0.0 |
| 30 Sept 2022 | Q3 | 46.4% | -361.0% | -373.7% | -33.2% | 5.01 | 1.58 | -0.0 |
| 30 Jun 2022 | Q2 | 32.0% | -394.8% | -105.7% | -26.5% | 1.63 | 1.90 | -0.0 |
| 31 Mar 2022 | Q1 | 27.8% | -548.6% | -57.7% | -22.8% | 0.84 | 2.99 | -0.0 |
| 31 Dec 2021 | Q4 | 52.9% | -180.4% | -49.9% | -17.0% | 1.13 | 2.73 | -0.1 |
| 30 Sept 2021 | Q3 | 61.0% | -178.2% | -30.2% | -13.0% | 0.80 | 3.93 | -0.2 |
| 30 Jun 2021 | Q2 | 53.2% | -126.1% | -14.2% | -7.0% | 0.59 | 5.03 | -0.2 |
| 31 Mar 2021 | Q1 | 45.3% | -337.8% | -28.8% | -13.2% | 0.71 | 4.22 | -0.1 |
| 31 Dec 2020 | Q4 | 58.9% | -166.1% | -29.6% | -12.2% | 0.87 | 4.54 | -0.1 |